Waverley Pharma Inc. (TSXV:WAVE)

Canada · Delayed Price · Currency is CAD

0.0150

0.00 (0.00%)

At close: Sep 15, 2026

Market Cap	810.00K
Revenue (ttm)	1.17M -6.2%
Net Income	-744.44K
EPS	-0.02
Shares Out	54.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Open	0.0150
Previous Close	n/a
Day's Range	0.0150 - 0.0150
52-Week Range	0.0100 - 0.0400
Beta	1.22
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2026

About Waverley Pharma

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops PARP-1 Inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. In addition, it is involved in the sale of prescription medications, over-the-counter products, and associated pharmacy services. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2014

Country Canada

Stock Exchange TSX Venture Exchange

Ticker Symbol WAVE

Full Company Profile

Financial Performance

In 2025, Waverley Pharma's revenue was 1.35 million, an increase of 183.90% compared to the previous year's 475,373. Losses were -499,214, -47.29% less than in 2024.

Financial Statements